. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: Am J Surg. 2013 Oct 7;207(1):10.1016/j.amjsurg.2013.05.014. doi: 10.1016/j.amjsurg.2013.05.014

Table 3.

Multivariable model of upgrade of ADH to cancer according to clinical and mammographic characteristics.

Post-menopausal		Pre-menopausal		Characteristic
^* p-value	OR (95% Cl)	^* p-value	OR (95% Cl)	Characteristic
0.78	1.01 (0.97, 1.04)	0.31	0.94 (0.84, 1.06)	Age at mammography, continuous in years
0.65	1.20 (0.53, 2.59)	0.0022	4.88 (1.80, 14.01)	Family history of breast cancer (yes vs. no)
0.0029	0.44 (0.20, 0.90)		N/A	Hormone therapy use (yes vs. no)
0.20	1.39 (0.85, 2.30)	0.70	1.14 (0.58, 2.29)	BI-RADS breast density (one-category change)
<0.0001	11.6 (4.45, 39.6)	0.0004	10.2 (3.23, 46.40)	Surgery^† within 6 months

included variables significant at 0.10 level from univariate models plus BCSC registry.

^†

including excisional biopsies, lumpectomies and mastectomies

CI-confidence interval